Joby Aviation
Search documents
Jim Cramer: Joby Is 'Losing Too Much Money'


Benzinga· 2025-11-12 13:00
Group 1: Aquestive Therapeutics - Jim Cramer described Aquestive Therapeutics, Inc. as a "very interesting spec" [1] - Piper Sandler analyst David Amsellem maintained an Overweight rating on Aquestive Therapeutics and raised the price target from $5 to $8 [1] - Shares of Aquestive Therapeutics gained 2% to close at $5.69 [4] Group 2: Amphenol Corporation - Cramer praised Amphenol Corporation as a "great" stock and recommended staying in the cable play [1] - Amphenol reported fiscal third-quarter 2025 results with quarterly sales increasing by 53% year-on-year to $6.19 billion, exceeding the analyst consensus estimate of $5.53 billion [1] - Adjusted EPS for Amphenol was 93 cents, beating the analyst consensus estimate of 80 cents [1] - Amphenol shares fell 0.3% to settle at $143.47 [4] Group 3: Joby Aviation - Cramer criticized Joby Aviation, Inc. for "losing too much money" [2] - Joby Aviation's third-quarter earnings report showed losses of 48 cents per share, missing the Street estimate for losses of 19 cents [2] - Joby Aviation shares rose 3.7% to settle at $16.35 [4]
This California-Based Company Could Be a High-Potential eVTOL Play Right Now
The Motley Fool· 2025-11-12 02:23
Business Model - Joby Aviation's business model focuses on providing transportation services rather than selling eVTOL aircraft to third parties, which allows for potentially greater upside through recurring revenues [2][5] - The company plans to operate under a vertically integrated model, manufacturing, owning, and operating its aircraft while offering an app-based aerial ridesharing service [4][5] Partnerships and Collaborations - Joby has a long-term partnership with Uber Technologies, having acquired Uber's Elevate planning unit and received a $75 million investment from Uber [6] - The company also acquired Blade's passenger business, integrating it into the Uber app for future eVTOL travel [6] - Joby collaborates with Toyota, which has committed to investing $894 million and is working with Joby's engineers on manufacturing solutions [9] Manufacturing Strategy - Unlike competitors like Archer Aviation and Vertical Aerospace, which rely on external partners for key components, Joby operates its own powertrain and electronics manufacturing facility [8] - This in-house manufacturing approach is part of Joby's strategy to maintain control over its technology and certification process [10] Certification Progress - Joby is ahead of competitors in the FAA certification process, being 77% complete on its side and 55% complete on the FAA side, with plans to begin certification flights early next year [11] - Archer is reported to be behind Joby in the certification process, indicating a potential advantage for Joby in terms of regulatory approval [11] Investment Potential - The combination of greater upside potential and relatively less risk due to Joby's progress in certification makes it an attractive stock for investors interested in the eVTOL sector [12]
Lightning Round: Joby Aviation is losing too much money, says Jim Cramer
CNBC Television· 2025-11-12 01:13
[Music] Wait a second. Only one sleep until Brooklyn. Tomorrow, I'm headed to the Barnes & Noble on Atlantic Avenue in Brooklyn, signing copies of my new book, How to Make Money in Any Market.6:30 p. m. And I can't wait to see you there and sign your books and talk about this wacky market.But now it is time to come to the light round by St. person, but you play this out and then the lightning round is over. Are you ready, Steve.Dang, the light round. I'm going to start with Alex in New York. Alex, >> James, ...
Cramer's Lighting Round: 'You want to stay in' Amphenol
CNBC· 2025-11-11 23:59
Group 1 - Amphenol is highlighted as a strong investment opportunity in the cable sector, with a positive outlook on its stock performance [1] - Aquestive Therapeutics is considered an interesting speculative investment, suggesting potential for growth despite inherent risks [1] - Joby Aviation is facing significant financial challenges, indicated by substantial losses, which raises concerns about its investment viability [1]
Joby Aviation: Bullish After The First Meaningful Revenue Print (NYSE:JOBY)
Seeking Alpha· 2025-11-10 21:45
Core Insights - The investor adopts a contrarian investment style, focusing on high-risk, illiquid options and shares, with a balanced portfolio of approximately 50% in each [1] - The investment strategy emphasizes buying stocks that have recently experienced sell-offs due to non-recurrent events, particularly when insiders are purchasing shares at lower prices [1] - Fundamental analysis is utilized to assess the health of companies, their leverage, and to compare financial ratios with sector and industry averages [1] - Technical analysis is employed to optimize entry and exit points, using multicolor lines for support and resistance levels on weekly charts [1] Investment Strategy - The investor's timeframe for holding positions ranges from 3 to 24 months [1] - A thorough screening process is conducted to identify potential investment opportunities, primarily focusing on U.S. stocks but also considering shares from other regions [1] - Professional background checks are performed on insiders who buy shares post-sell-off to ensure credibility and potential for recovery [1]
Joby Aviation: Bullish After The First Meaningful Revenue Print
Seeking Alpha· 2025-11-10 21:45
Core Viewpoint - The individual investor adopts a contrarian investment style, focusing on deep value opportunities, particularly in stocks that have recently experienced sell-offs due to non-recurrent events, while also considering insider buying as a positive signal [1] Investment Strategy - The investment portfolio is split approximately 50%-50% between shares and call options, indicating a balanced approach between equity and derivatives [1] - The investor's timeframe for holding positions typically ranges from 3 to 24 months, suggesting a medium-term investment horizon [1] - Fundamental analysis is employed to assess the health of companies, including their leverage and financial ratios compared to sector and industry averages [1] - Technical analysis is utilized to optimize entry and exit points, with a focus on support and resistance levels on weekly charts [1] Stock Selection Criteria - Preference is given to stocks that have undergone a recent sell-off, particularly when there is insider buying at the new lower price, indicating potential recovery [1] - The investor screens through thousands of stocks, primarily in the US, but is open to owning shares in less stable markets, referred to as "banana republics" [1] - Professional background checks are conducted on insiders who purchase shares post-sell-off to ensure credibility and alignment with shareholder interests [1]
Blade(BLDE) - 2025 Q3 - Earnings Call Presentation
2025-11-10 13:00
Financial Performance & Acquisitions - Strata's Q3 2025 revenue reached $493 million, a 37% year-over-year increase, with 29% organic growth excluding the Keystone acquisition[5] - The acquisition of Keystone Perfusion contributed approximately $28 million to Strata's Q3 2025 revenue[6] - Adjusted EBITDA for Q3 2025 was $42 million, representing an 85% margin[5] - Strata sold its passenger business to Joby Aviation for $125 million[14] - Strata acquired Keystone Perfusion for $124 million upfront, with potential earn-outs of $23 million based on gross profit targets[15] Market Position & Growth Strategy - Strata estimates its market share to be approximately 30% in air logistics and 15% in ground logistics for organ transport[11] - The company is focused on expanding its transplant clinical services, particularly Normothermic Regional Perfusion (NRP), driven by a 20%+ CAGR in Donation after Circulatory Death (DCD) donors[43] - Strata aims to increase aircraft utilization and improve operating costs by expanding into other time-critical logistics verticals[55] Organ Transplant Trends - The distance of heart, liver, and lung transplants has increased by 64% from 2018 to 2024 due to regulatory changes and new technologies[39] - Normothermic Regional Perfusion (NRP) penetration of DCD donors has increased to approximately 40% by Q3 2025[43] - U S heart, liver, and lung transplants have grown at a CAGR of 38% from 2010-2024[27]
Strata Critical Medical Announces Third Quarter 2025 Results
Globenewswire· 2025-11-10 12:00
Core Insights - Strata Critical Medical, Inc. reported a revenue increase of 36.7% year-over-year to $49.3 million for Q3 2025, with organic growth of 29.0% excluding the Keystone acquisition [4][6] - The company experienced a net loss from continuing operations of $(9.7) million, an increase from $(5.6) million in the prior year [4][6] - Adjusted EBITDA for the Medical Segment rose by 93.5% to $7.6 million, reflecting strong operational performance [4][6] Financial Results - Total revenue for Q3 2025 was $49,298 thousand, compared to $36,062 thousand in Q3 2024, marking a 36.7% increase [2] - Cost of revenue increased by 32.0% to $37,684 thousand in Q3 2025 from $28,554 thousand in Q3 2024 [2] - Gross profit for Q3 2025 was $9,545 thousand, up from $5,427 thousand in the prior year, resulting in a gross margin of 19.4% [2][6] Operating Expenses - Total operating expenses increased by 27.3% to $54,920 thousand in Q3 2025 from $43,154 thousand in Q3 2024 [2] - General and administrative expenses rose by 17.5% to $16,301 thousand in Q3 2025 [2] - Selling and marketing expenses increased significantly by 53.5% to $482 thousand [2] Adjusted Metrics - Adjusted EBITDA for Q3 2025 was $4,214 thousand, a substantial increase from $67 thousand in Q3 2024 [3][4] - Medical Segment Adjusted EBITDA margin improved to 15.3% in Q3 2025 from 10.8% in Q3 2024 [5][6] - Flight Profit increased by 54.7% to $11,614 thousand, with a Flight Margin of 23.6% [3][6] Business Developments - The company raised its 2025 revenue guidance to $185-195 million, up from the previous range of $180-190 million [4][14] - Strata completed the divestiture of its Passenger business and the acquisition of Keystone Perfusion, positioning itself for long-term growth [4][14] - The integration of Keystone is reported to be progressing well, with a focus on operational efficiencies [4][6] Cash Flow and Capital Expenditures - Operating cash flow was $(37.3) million in Q3 2025, influenced by acquisition-related payments [6] - Capital expenditures for the quarter were $3.2 million, primarily for aircraft maintenance [6][13] - The company ended Q3 2025 with $75.9 million in cash and short-term investments [13]
Tokyo Metropolitan Government Selects Multi-Use Case Implementation Project Featuring SkyDrive and Joby Aviation Aircraft for “eVTOL Implementation Project (Phase I)"
Businesswire· 2025-11-10 05:10
Group 1 - SkyDrive Inc., a leading eVTOL aircraft manufacturer in Japan, has been selected for the "eVTOL Implementation Project (Phase I)" by the Tokyo Metropolitan Government [1] - The consortium leading the project includes notable companies such as Nomura Real Estate Development Co., Ltd., ANA Holdings Inc., East Japan Railway Company, Aero Toyota Corporation, Seibu Holdings Inc., and Nikken Sekkei Ltd. [1] - The project aims to utilize advanced eVTOL technology to enhance urban mobility solutions in Tokyo [1]
进博会上多项低空经济订单签约,时的科技总部落户上海 | 投研报告
Zhong Guo Neng Yuan Wang· 2025-11-10 02:02
Core Insights - The report highlights significant developments in the low-altitude economy, particularly the establishment of a headquarters and manufacturing base by a technology company in Shanghai, which aims to centralize R&D, manufacturing, certification, and sales [2] Group 1: Company Developments - On November 6, a technology company signed a strategic cooperation agreement with the Shanghai Municipal Economic and Information Commission and the Minhang District Government, announcing the establishment of its headquarters and manufacturing base in Shanghai Minhang [2] - The company secured a credit line of 700 million yuan and signed a procurement agreement for 100 E20eVTOL aircraft with ICBC Financial Leasing, alongside completing a 300 million yuan B++ round of financing [2] - This strategic move is expected to enhance the advanced manufacturing industry chain in the Yangtze River Delta and explore a model of "Shanghai R&D, global application" [2] Group 2: Industry Orders and Collaborations - At the 8th China International Import Expo, Volant Aeronautics signed agreements with several companies, securing a total of 95 eVTOL orders worth 2.375 billion yuan [2] - The company also received a high-level commercial confirmation order for eVTOL passenger transport, along with a deposit of several million yuan [2] - Additionally, Yufeng Future showcased its upgraded passenger eVTOL product M1 and signed a letter of intent for 200 aircraft orders worth over 2 billion yuan, with plans for 100 aircraft to be used in domestic and international low-altitude transportation networks [2] Group 3: Industry Trends and Projects - On November 8, Jinan signed contracts for eight low-altitude economy projects, including the AS700 manned airship delivery center and industrial drone manufacturing base, covering the entire chain from aircraft R&D to infrastructure and application scenarios [2] - The AS700 airship delivery center is expected to fill the gap in high-end manned aircraft manufacturing in the northern region, supporting low-altitude tourism and emergency command scenarios [2] - The report suggests that the low-altitude economy is witnessing vertical implementation from macro (national industrial planning) to micro (infrastructure bidding and application scenario development), recommending attention to subsequent market trends in the low-altitude economy [2]